Nicoya, a Canadian life sciences tools company specialising in innovative biosensor technology for the academic and biopharmaceutical sectors, is expanding its operation in India by appointing Mumbai-based Medispec as its exclusive distributor. This strategic partnership marks a significant milestone in Nicoya's commitment to providing cutting-edge research solutions to the scientific community around the globe.

Nicoya is known for its state-of-the-art Alto and OpenSPR platforms that are designed to accelerate biomolecular interaction studies and lead screening during drug discovery. With a mission to improve human life by helping scientists succeed, Nicoya is excited to collaborate with Medispec to bring its groundbreaking technologies to the Indian market as demand grows. 

Medispec, a prominent and trusted name in the distribution of life science and medical research instruments, brings a wealth of expertise and a strong reputation for delivering high-quality products and exceptional customer service. Their dedication to supporting scientific advancements aligns seamlessly with Nicoya's vision, making them the ideal partner to represent Nicoya in India.

Commenting on the partnership, Ryan Denomme, CEO at Nicoya, said, "Medispec's reputation for excellence and commitment to customer success align perfectly with Nicoya's values, and we are confident that this collaboration will help promote scientific advancements in India.”

Vikkalp Chhatbar, Head of Business Development at Medispec, added, “Introducing Nicoya's innovative biosensor platforms to the Indian market, we aim to contribute significantly to the success of scientific endeavors in India."